Miru 1day UpSide (midafilcon A)
Menicon Co, Ltd. · Decision date Sep 17, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-17 for K262495, submitted by Menicon Co, Ltd. of Nagoya, Japan, for the device Miru 1day UpSide (midafilcon A). The application is a traditional 510(k) received on 07/20/2026, reviewed by FDA rather than a third party, and not recorded as a combination product. A SESE decision is a clearance finding, not a premarket approval of the device.
The device falls under regulation number 886.5925 in the Ophthalmic medical specialty, with classification product code LPL and subsequent product code MVN; the FDA page lists the classification name as Lenses, Soft Contact, Daily Wear. The record does not state which predicate device was used, what testing supported equivalence, or any labeling, wear-schedule or indication details. The linked summary document was not part of the public information, so its contents remain unknown.
The correspondent of record is Andre Vision and Device Research of West Linn, Oregon, with Bret Andre listed as correspondent contact and Kana Nagasaki as applicant contact. No clinical, performance or postmarket data appear in the public information, and nothing in it supports conclusions about safety, efficacy or current labeling.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Ophthalmic
- Decision date
- Sep 17, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262495
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Menicon Co, Ltd.
- Product code
- LPL
- Decision code
- SESE
- Decision date
- Sep 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lenses, Soft Contact, Daily Wear.
- Applicant
- Menicon Co, Ltd.
- Product code
- LPL
- FDA device class
- 2
FDA decision timeline
K262495 received
Application receipt date recorded by FDA.
K262495 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LPL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| St. shine Optical Co., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| Visco Vision, Inc. | 510(k) clearance | Oct 23, 2026 | FDA | |
| Bausch + Lomb, Inc. | 510(k) clearance | Oct 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Menicon Co, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Nagoya
Sources and methodology
- Original FDA record: K262495
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

